Mexico’s New Abbreviated Regulatory Pathway: A Game-Changer for Healthcare Market Entry
Unlocking Latin American Opportunities with Streamlined COFEPRIS Approvals The Mexican healthcare market, a vibrant and expanding landscape, is poised for a significant transformation with the introduction of new regulatory guidelines by the Federal Commission for the Protection against Sanitary Risks (COFEPRIS). Published in the Diario Oficial de la Federación on July 18, 2025, these guidelines […]
Brazil and Mexico Form Strategic Health Integration Alliance
Leaders from ANVISA and Mexico’s COFEPRIS ratified the “Rio de Janeiro Declaration” in April 2026. This partnership focuses on regulatory convergence and reducing regional dependence on imported medicines. For advisory firms like BioIntell, this signifies a more harmonized regulatory landscape between Latin America’s two largest economies. Read more: Brazil and Mexico celebrate health integration and […]